Received May 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | — | — |
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | — |
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
| HEP | HEP B (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
HBsAg positive after booster dose; This literature marketed report has been received from the authors of a published article, and refers to a 24-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included obesity. Concomitant therapies were not reported. On unknown dates, the patient received the series of 3 vaccinations with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (doses, route of administration, lot # and expiration dates were not reported) for prophylaxis. On an unknown date, the patient received additional dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (dose, route of administration, lot # and expiration date were not reported) for prophylaxis, due to not having protective HBV antibody titers after 3 doses of HBV vaccine (captured in case# 2277533). On an unknown date, hepatitis B surface antigen (HBsAg) showed positive, which was considered to be a false positive test due to the vaccine. On an unknown date, the patient recovered from the event, as later, on an unknown date (reported as now), the HBsAg was negative. The reporter considered the event to be related to Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB). This is one of two cases derived from the same literature article (cross referenced with case# 2277533).
Medical History/Concurrent Conditions: Obesity
Test Name: hepatitis B surface antigen; Test Result: Positive ; Test Name: Hepatitis B surface antigen; Test Result: Negative